S R Granter
Overview
Explore the profile of S R Granter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alloo A, Khosravi H, Granter S, Jadeja S, Richardson P, Castillo J, et al.
Support Care Cancer
. 2018 Feb;
26(7):2247-2250.
PMID: 29392482
Ixazomib is a second-generation proteasome inhibitor that has been approved in the combination treatment of multiple myeloma and is currently under clinical investigation for the management of Waldenstrom's macroglobulinemia. While...
2.
Cohen J, Granter S, Werchniak A
Clin Exp Dermatol
. 2015 May;
40(5):473-8.
PMID: 26011765
Extramammary Paget disease (EMPD) is an uncommon intraepithelial adenocarcinoma that involves body sites with apocrine glands such as the genital, perineal and perianal regions. Risk stratification and treatment planning for...
3.
Li Q, Yang X, Xu F, Sharma C, Wang H, Knoblich K, et al.
Oncogene
. 2012 Jul;
32(14):1772-83.
PMID: 22824799
Here we provide the first evidence that tetraspanin CD151 can support de novo carcinogenesis. During two-stage mouse skin chemical carcinogenesis, CD151 reduces tumor lag time and increases incidence, multiplicity, size...
4.
Saavedra A, Bueno E, Granter S, Pomahac B
Am J Transplant
. 2011 Jun;
11(6):1340.
PMID: 21645261
No abstract available.
5.
Culpepper K, Granter S, McKee P
J Clin Pathol
. 2004 Oct;
57(11):1121-31.
PMID: 15509670
Histological assessment of melanocytic naevi constitutes a substantial proportion of a dermatopathologist's daily workload. Although they may be excised for cosmetic reasons, most lesions encountered are clinically atypical and are...
6.
Kroumpouzos G, Avgerinou G, Granter S
Br J Dermatol
. 2002 May;
146(5):925-8.
PMID: 12000404
No abstract available.
7.
Wieczorek T, Krane J, Domanski H, Akerman M, Carlen B, Misdraji J, et al.
Cancer
. 2001 Dec;
93(6):398-408.
PMID: 11748580
Background: Granular cell tumors (GCTs) are uncommon tumors of putative schwannian derivation that are rarely malignant. Although recent studies have addressed a histologic correlation with malignant behavior, similar studies have...
8.
Granter S, Weilbaecher K, Quigley C, Fletcher C, Fisher D
Am J Dermatopathol
. 2001 Jun;
23(3):185-9.
PMID: 11391097
Microphthalmia transcription factor (Mitf), a melanocytic nuclear protein critical for the embryonic development and postnatal viability of melanocytes, is a master lineage regulator and modulates extracellular signals. Recently, Mitf expression...
9.
Zembowicz A, McCusker M, Chiarelli C, Dei Tos A, Granter S, Calonje E, et al.
Am J Dermatopathol
. 2001 Jun;
23(3):167-75.
PMID: 11391094
Nevoid melanoma is a rare variant of melanoma characterized by deceptive morphologic features reminiscent of a benign melanocytic nevus. Twenty (13 nodular, 7 verrucous) nevoid melanomas were reviewed with the...
10.
Krane J, Granter S, Trask C, Hogan C, Lee K
Cancer
. 2001 Mar;
93(1):8-15.
PMID: 11241260
Background: Papanicolaou smear sensitivity for cervical adenocarcinoma (CVCA) is not well established. Also uncertain are the relative contributions to falsely negative diagnoses of sampling, screening, and interpretive errors. Methods: Papanicolaou...